Element Capital Management LLC Halozyme Therapeutics, Inc. Transaction History

Element Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$13.33 - $18.66 $150,842 - $211,156	-11,316 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $188,750 - $208,327	11,316 New	11,316 $206,000
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $170,572 - $205,253	-10,111 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $172,493 - $214,353	10,111 New	10,111 $198,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.